Skip to main content

(Approval lapsed) Isoproterenol Hydrochloride Injection, USP 1mg/5mL solution for ampoule

Section 19A approved medicine
(Approval lapsed) Isoproterenol Hydrochloride Injection, USP 1mg/5mL solution for ampoule
Section 19A approval holder
Reach Pharmaceuticals Pty Ltd ABN 25 623 897 183
Phone
0478 061 879
Approved until
Status
Expired
Indication(s)
  • For mild or transient episodes of heart block that do not require electric shock or pacemaker therapy
  • For serious episodes of heart block and Adams-Stoke attacks (except when caused by ventricular tachycardia or fibrillation).
  • For use in cardiac arrest until electric shock or pacemaker therapy, the treatments of choice, is available.
  • For bronchospasm occurring during anaesthesia.
  • As an adjunct to fluid and electrolyte replacement therapy and the use of other drugs and procedures in the treatment of hypovolaemic and septic shock, low cardiac output (hypoperfusion) states, congestive heart failure, and cardiogenic shock.

Help us improve the Therapeutic Goods Administration site